Metabolic dysfunction-associated steatotic liver disease (MASLD) can be a possible predictive factor of incident CKD: NAGALA cohort study.

<h4>Background</h4>A decade-long follow-up study identified metabolic dysfunction-associated fatty liver disease (MAFLD) as an independent predictor for the onset of chronic kidney disease (CKD). In 2023, a Delphi consensus introduced the term metabolic dysfunction-associated steatotic l...

Full description

Bibliographic Details
Published in:PLoS ONE
Main Authors: Yuriko Ono, Kimiko Sakai, Takuro Okamura, Hiroshi Okada, Akihiro Obora, Takao Kojima, Masahide Hamaguchi, Michiaki Fukui
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Online Access:https://doi.org/10.1371/journal.pone.0334720

Similar Items

Similar Items